JPH05244993A - Improved method for colorimetric determination of mtt - Google Patents
Improved method for colorimetric determination of mttInfo
- Publication number
- JPH05244993A JPH05244993A JP4934992A JP4934992A JPH05244993A JP H05244993 A JPH05244993 A JP H05244993A JP 4934992 A JP4934992 A JP 4934992A JP 4934992 A JP4934992 A JP 4934992A JP H05244993 A JPH05244993 A JP H05244993A
- Authority
- JP
- Japan
- Prior art keywords
- mtt
- hydrochloric acid
- isopropyl alcohol
- colorimetric determination
- alcohol containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、細胞増殖能や細胞機能
試験に用いるMTT比色定量方法の改良に関するもの
で、更に詳しくは生成MTTホルマザン結晶の溶解方法
に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an improvement in the MTT colorimetric quantification method used for cell growth ability and cell function tests, and more particularly to a method for dissolving produced MTT formazan crystals.
【0002】[0002]
【従来の技術】インビトロでの細胞増殖能や細胞機能試
験法としては、ラジオアイソトープ(RI)で標識した
チミジン(3H−TdR)の細胞内への取り込みを測定
する方法が一般的に用いられている。しかし、RIを用
いるため被爆の危険性があり、またRI施設を必要とす
るため使用には制限がある。2. Description of the Related Art As a method for testing in vitro cell proliferation ability and cell function, a method of measuring uptake of radioisotope (RI) -labeled thymidine ( 3 H-TdR) into cells is generally used. ing. However, since RI is used, there is a risk of being exposed to radiation, and because RI facilities are required, its use is limited.
【0003】そのため3H−TdR法に代替し得る方法
が多く検討されているが、Mosmannにより開発さ
れたMTT比色定量法(ジャーナル オブ イムノロジカ
ルメソッズ 63:55−63、1983)は、非RI
で迅速かつ簡便であるため、多く用いられつつある。M
TT比色定量法は、淡黄色のMTT(3-(4,5-ジメチル
チアゾール-2-イル)-2,5-ジフェニルテトラゾリウムブ
ロミド)が生細胞のミトコンドリア、特にその呼吸鎖に
選択的に作用し、同部分の形成に関与する酵素によりM
TTが開裂、還元され暗青色のMTTホルマザン色素が
生成することを利用したもので、このホルマザン量は比
色定量が可能であり、生細胞の増殖能と比例関係にあ
る。生成したMTTホルマザン色素結晶の溶解方法とし
ては、培養液に0.04N塩酸含有イソプロピルアルコ
ール液を加えピペッティングするか、又は10%ドデシ
ル硫酸ナトリウム(SDS)−0.04N塩酸を添加後
すばやく混和し、一晩37℃に静置する等の方法が使用
されているが、MTTホルマザン色素結晶の溶解性が悪
く前者ではピペッティングに手間がかかり後者では時間
がかかるという問題点がある。Therefore, many methods that can be substituted for the 3 H-TdR method have been studied, but the MTT colorimetric method developed by Mosmann (Journal of Immunological Methods 63: 55-63, 1983) is a non-RI method.
It is being used more and more because it is quick and simple. M
In the TT colorimetric method, pale yellow MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide) selectively acts on mitochondria of living cells, especially its respiratory chain. The enzyme involved in the formation of
It utilizes the fact that TT is cleaved and reduced to produce a dark blue MTT formazan dye. The amount of this formazan can be colorimetrically determined and is proportional to the proliferative ability of living cells. As a method for dissolving the produced MTT formazan dye crystals, 0.04N hydrochloric acid-containing isopropyl alcohol solution is added to the culture solution and pipetting, or 10% sodium dodecylsulfate (SDS) -0.04N hydrochloric acid is added and rapidly mixed. Although the method of leaving it at 37 ° C. overnight is used, there is a problem that the solubility of MTT formazan dye crystals is poor and the former requires time and effort for pipetting and the latter takes time.
【0004】[0004]
【発明が解決しようとする課題】従って本発明の目的
は、MTT比色定量方法で細胞増殖能や細胞機能試験を
行う際、上記の如く生成するMTTホルマザン結晶が難
溶性であるため溶解に手間と時間がかかるという問題を
解決する手段を提供することにある。SUMMARY OF THE INVENTION Therefore, an object of the present invention is to dissolve a MTT formazan crystal, which is produced as described above, when it is tested for cell growth ability and cell function by an MTT colorimetric assay method. It is to provide a means for solving the problem of taking time.
【0005】[0005]
【課題を解決するための手段】上記課題は、生成MTT
ホルマザン結晶溶解にジメチルホルムアミド(DMF)
と塩酸含有イソプロピルアルコールとの混合液又はジメ
チルスルホキシド(DMSO)と塩酸含有イソプロピル
アルコールとの混合液を用いることにより解決された。[Means for Solving the Problems] The above-mentioned problem is to generate MTT.
Dimethylformamide (DMF) for dissolving formazan crystals
It was solved by using a mixed solution of isopropyl alcohol containing hydrochloric acid or a mixed solution of dimethyl sulfoxide (DMSO) and isopropyl alcohol containing hydrochloric acid.
【0006】従来のMTT比色定量法の代表的な手順で
は、RPMI1640培地+10%仔ウシ血清を用いて
調製した細胞浮遊液100μlを96穴平底型マイクロ
プレートの各ウェルに分注し、一定時間37℃、5%C
O2培養器に静置する。その後MTT液(MTT5mg
を1mlのPBS(−)で溶解後、濾過滅菌したもの)
10μlを添加し、37℃で2〜6時間反応させる。次
に、生成したMTTホルマザン結晶を溶解するため、
0.04N塩酸含有イソプロピルアルコール液100μ
lを添加しピペッティングをするか、又は10%SDS
−0.04N塩酸液100μlを添加後すばやく混和し
一晩37℃に静置した後、MTTホルマザン量を570
nmと630nmの吸光度差で定量する。[0006] In a typical procedure of the conventional MTT colorimetric assay, 100 μl of a cell suspension prepared by using RPMI1640 medium + 10% calf serum is dispensed into each well of a 96-well flat-bottomed microplate and kept for a certain period of time. 37 ° C, 5% C
Place in O 2 incubator. After that, MTT liquid (MTT 5 mg
Was dissolved in 1 ml of PBS (-) and sterilized by filtration)
10 μl is added, and the mixture is reacted at 37 ° C. for 2 to 6 hours. Next, in order to dissolve the produced MTT formazan crystal,
0.04N Hydrochloric Acid-Containing Isopropyl Alcohol Solution 100μ
Add l and pipet or 10% SDS
After adding 100 μl of −0.04N hydrochloric acid solution, the mixture was quickly mixed and allowed to stand at 37 ° C. overnight, and the amount of MTT formazan was adjusted to 570.
Quantitation is performed by the difference in absorbance between nm and 630 nm.
【0007】本発明方法においては、上記塩酸含有イソ
プロピルアルコール液又はSDS−塩酸液の代わりにD
MFと塩酸含有イソプロピルアルコールとの混合液又は
DMSOと塩酸含有イソプロピルアルコールとの混合液
を使用するものである。この本発明方法によりMTTホ
ルマザン結晶は容易かつ迅速に溶解し、従来法の問題点
は解決され、迅速かつ簡便にMTT比色定量を行うこと
が可能である。In the method of the present invention, D is used instead of the isopropyl alcohol solution containing hydrochloric acid or the SDS-hydrochloric acid solution.
A mixed solution of MF and isopropyl alcohol containing hydrochloric acid or a mixed solution of DMSO and isopropyl alcohol containing hydrochloric acid is used. According to the method of the present invention, the MTT formazan crystal is easily and quickly dissolved, the problems of the conventional method are solved, and MTT colorimetric determination can be carried out quickly and easily.
【0008】本発明によるMTTホルマザン結晶溶解方
法の好適な実施態様を以下に説明する。本発明方法は、
MTTホルマザン結晶を溶解するためにDMFと塩酸含
有イソプロピルアルコールとの混合液又はDMSOと塩
酸含有イソプロピルアルコールとの混合液を使用する以
外は従来のMTT比色定量法と同様の手順により実施す
ることができる。従って、先ず被験細胞を含む細胞浮遊
液とMTTを従来のMTT比色法と同様に2〜6時間反
応させた後、これにDMFと塩酸含有イソプロピルアル
コールとの混合液又はDMSOと塩酸含有イソプロピル
アルコールとの混合液を添加し、軽く超音波照射又は振
盪することにより生成した結晶を溶解する。この際、4
0℃程度に加温することが好ましい。細胞浮遊液と混合
液の混合比率については、混合液の比率が高い方が溶解
性が高いが、タンパクを溶解する場合には混合液の比率
が大きいと血清タンパクの沈澱を生じ吸光度に影響を与
えることになる。これらの観点から、細胞浮遊液と混合
液の混合比率は、好ましくは1:2〜2:1である。A preferred embodiment of the MTT formazan crystal dissolution method according to the present invention will be described below. The method of the present invention is
The same procedure as the conventional MTT colorimetric method can be performed except that a mixed solution of DMF and isopropyl alcohol containing hydrochloric acid or a mixed solution of DMSO and isopropyl alcohol containing hydrochloric acid is used to dissolve the MTT formazan crystals. it can. Therefore, first, a cell suspension containing test cells and MTT are reacted for 2 to 6 hours in the same manner as in the conventional MTT colorimetric method, and then a mixed solution of DMF and isopropyl alcohol containing hydrochloric acid or DMSO and isopropyl alcohol containing hydrochloric acid is added. The resulting mixture is added, and the resulting crystals are dissolved by lightly irradiating with ultrasonic waves or shaking. At this time, 4
It is preferable to heat to about 0 ° C. Regarding the mixing ratio of the cell suspension and the mixed solution, the higher the ratio of the mixed solution is, the higher the solubility is. However, when the protein is dissolved, when the ratio of the mixed solution is large, the precipitation of the serum protein is caused and the absorbance is affected. Will be given. From these viewpoints, the mixing ratio of the cell suspension and the mixed solution is preferably 1: 2 to 2: 1.
【0009】細胞浮遊液とDMFと塩酸含有イソプロピ
ルアルコールとの混合液又はDMSOと塩酸含有イソプ
ロピルアルコールとの混合液とは等量で混合されるのが
好ましく、その場合イソプロピルアルコールの塩酸含有
量は0.04N程度とするのが好ましい。またDMFと
塩酸含有イソプロピルアルコール及びDMSOと塩酸含
有イソプロピルアルコールとの混合比率は、1:9〜
9:1とすることができ、特に1:9〜1:1が好まし
く、1:9が最も好ましい。The cell suspension, the mixed solution of DMF and isopropyl alcohol containing hydrochloric acid or the mixed solution of DMSO and isopropyl alcohol containing hydrochloric acid are preferably mixed in equal amounts, in which case the hydrochloric acid content of isopropyl alcohol is 0. It is preferably about 0.04N. The mixing ratio of DMF and isopropyl alcohol containing hydrochloric acid and DMSO and isopropyl alcohol containing hydrochloric acid is from 1: 9 to
It can be 9: 1, particularly preferably 1: 9 to 1: 1 and most preferably 1: 9.
【0010】それでも溶解しにくい場合は、細胞浮遊液
をMTTと反応させた後遠心して培地を一定量取り除い
た後にDMFと塩酸含有イソプロピルアルコールとの混
合液又はDMSOと塩酸含有イソプロピルアルコールと
の混合液を添加し、MTTホルマザン結晶溶解時のDM
Fと塩酸含有イソプロピルアルコールとの混合液又はD
MSOと塩酸含有イソプロピルアルコールとの混合液の
相対量を多くし、さらに40℃程度に加温して超音波照
射するか又は振盪することができる。If it is still difficult to lyse, the cell suspension is reacted with MTT and then centrifuged to remove a certain amount of the medium, and then a mixed solution of DMF and isopropyl alcohol containing hydrochloric acid or a mixed solution of DMSO and isopropyl alcohol containing hydrochloric acid. Was added to the DM to dissolve the MTT formazan crystals.
Mixed liquid of F and isopropyl alcohol containing hydrochloric acid or D
The relative amount of the mixed solution of MSO and isopropyl alcohol containing hydrochloric acid can be increased, and the mixture can be heated to about 40 ° C. and irradiated with ultrasonic waves or shaken.
【0011】溶解を促進するための超音波照射には水浴
型超音波照射器を用いることができ、振盪にはマイクロ
プレート用ミキサーを用いることができる。本発明によ
るMTT比色定量法は細胞増殖能試験、培養細胞の生存
率測定、細胞機能試験(補体関与の細胞溶解試験な
ど)、抗原に対する細胞性免疫応答測定、抗癌剤などの
薬剤感受性試験、免疫抑制又は賦活剤スクリーニング等
に応用できる。 以下実施例により本発明をさらに詳細
に説明するが、本発明はこれに限定されるものではな
い。A water bath type ultrasonic wave irradiator can be used for ultrasonic wave irradiation for promoting dissolution, and a microplate mixer can be used for shaking. The MTT colorimetric assay according to the present invention comprises a cell proliferation ability test, culture cell viability measurement, cell function test (complement-related cell lysis test, etc.), measurement of cell-mediated immune response to antigen, drug sensitivity test of anticancer drug, etc. It can be applied to immunosuppression or activator screening. Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.
【0012】[0012]
実施例1MTTホルマザン結晶の溶解 末梢血より精製したヒトリンパ球を、10%仔ウシ血清
を含むRPMI1640培地を用いて2.0×106個
/mlの濃度に調整し、50μlずつ96穴マイクロプ
ートの各ウェルに分注した。更に10μg/mlに調整
したPHA(フィトヘマグルチニン)を50μlずつ添
加し、37℃、5%CO2培養器で72時間培養した。
培養終了後、MTT液(MTT5mgを1mlのPBS
で溶解後、濾過滅菌したもの)10μlを加え、37℃
で6時間反応させた後、生成したMTTホルマザン結晶
を各種溶媒により溶解した。結果を下表に示す。 ─────────────────────────────────── 使用した溶媒及び溶解促進操作 溶解性 溶解時間 ─────────────────────────────────── HCl-IPA、ピペッティング (従来法) ○ 20分 0.04N塩酸含有10%SDS、一夜静置 (従来法) ○ 一夜 0.04N塩酸含有0.3%SDS、一夜静置 (従来法) ○ 一夜 HCl-IPA:DMSO=9:1、超音波照射、加温 ◎ 2分 HCl-IPA:DMSO=1:1、超音波照射、加温 ○ 2分 HCl-IPA:DMF =9:1、超音波照射、加温 ◎ 2分 HCl-IPA:DMF =1:1、超音波照射、加温 ○ 2分 ─────────────────────────────────── 溶解性 ○:OD565/OD600 = 1.3以上 ◎:OD565/OD600 = 1.3未満 略号 HCl−IPA:0.04N塩酸含有イソプロ
ピルアルコール SDS:ドデシル硫酸ナトリウム DMF:ジメチルホルムアミド DMSO:ジメチルスルホキシド 実施例2ヒトリンパ球のレクチン刺激による増殖測定 ヒトリンパ球を10%仔ウシ血清を含むRPMI164
0培地を用いて2.0×106個/mlに調整し、50
μlずつ96穴マイクロプレートの各ウェルに分注し
た。更に4〜100μg/mlに調整したPHA50μ
lを添加し、37℃、5%CO2培養器で72時間培養
した。培養終了後、MTT液(MTT5mgを1mlの
PBS(−)で溶解後、濾過滅菌)10μlを加えた。
6時間後、生成されたMTTホルマザン結晶をDMFと
0.04N塩酸含有イソプロピルアルコールとの混合比
率1:9の溶媒100μlを加え、40℃程度に加温し
て軽く超音波照射し溶解した。生成MTTホルマザンの
吸光度をもってリンパ球増殖を測定した。Example 1 Lysis of MTT formazan crystals Human lymphocytes purified from peripheral blood were adjusted to a concentration of 2.0 × 10 6 cells / ml using RPMI1640 medium containing 10% calf serum, and 50 μl each of 96-well microplates. Of each well. Further, 50 μl of PHA (phytohemagglutinin) adjusted to 10 μg / ml was added, and the mixture was cultured at 37 ° C. in a 5% CO 2 incubator for 72 hours.
After completion of culture, MTT solution (MTT 5 mg was added to 1 ml of PBS).
(10 μl after being sterilized by filtration and sterilized by filtration) was added, and the temperature was 37 ° C.
After reacting for 6 hours, the produced MTT formazan crystals were dissolved in various solvents. The results are shown in the table below. ─────────────────────────────────── Solvent used and dissolution promotion operation Solubility Dissolution time ──── ─────────────────────────────── HCl-IPA, pipetting (conventional method) ○ 20 minutes 10% containing 0.04N hydrochloric acid SDS, overnight standing (conventional method) ○ Overnight 0.04N hydrochloric acid containing 0.3% SDS, overnight standing (conventional method) ○ Overnight HCl-IPA: DMSO = 9: 1, ultrasonic irradiation, heating ◎ 2 minutes HCl-IPA : DMSO = 1: 1, ultrasonic irradiation, heating ○ 2 minutes HCl-IPA: DMF = 9: 1, ultrasonic irradiation, heating ◎ 2 minutes HCl-IPA: DMF = 1: 1, ultrasonic irradiation, heating Temperature ○ 2 minutes ─────────────────────────────────── Solubility ○: OD 565 / OD 600 = 1.3 more ◎: abbreviations less than OD 565 / OD 600 = 1.3 HCl -IPA: 0.04N hydrochloric acid containing iso B Pill alcohol SDS: sodium dodecyl sulfate DMF: dimethylformamide DMSO: dimethyl sulfoxide Example contains 2 human lymphocyte proliferation measured human lymphocytes by lectin stimulation of 10% calf serum RPMI164
Adjust to 2.0 × 10 6 cells / ml using 0 medium, and
μl was dispensed into each well of a 96-well microplate. Further, PHA 50μ adjusted to 4 to 100 μg / ml
1 was added and the cells were cultured at 37 ° C. in a 5% CO 2 incubator for 72 hours. After the culture was completed, 10 μl of MTT solution (5 mg of MTT was dissolved in 1 ml of PBS (−) and sterilized by filtration) was added.
After 6 hours, 100 μl of a solvent having a mixing ratio of DMF and isopropyl alcohol containing 0.04 N hydrochloric acid of 1: 9 was added to the produced MTT formazan crystal, and the mixture was heated to about 40 ° C. and lightly irradiated with ultrasonic waves to dissolve. Lymphocyte proliferation was measured by the absorbance of the produced MTT formazan.
【0013】結果を図1に示す。図1は、添加PHA濃
度と生成MTTホルマザンの吸光度差をプロットしたグ
ラフである。本方法によりPHA刺激の指適濃度は5μ
g/mlと求められた。これは、3H−TdR法で求め
た値と一致する。The results are shown in FIG. FIG. 1 is a graph in which the difference in absorbance between the added PHA concentration and the produced MTT formazan is plotted. With this method, the optimum concentration of PHA stimulation is 5μ
It was determined to be g / ml. This agrees with the value obtained by the 3 H-TdR method.
【図1】 ヒトリンパ球のレクチン刺激による増殖測定
試験において本発明方法を使用して測定した生成MTT
ホルマザンの吸光度差と添加PHA濃度との関係を示す
図である。FIG. 1 Produced MTT measured using the method of the invention in a lectin-stimulated proliferation assay of human lymphocytes.
It is a figure which shows the relationship between the light absorbency difference of formazan, and the addition PHA density | concentration.
Claims (1)
ルホルムアミドと塩酸含有イソプロピルアルコールとの
混合液又はジメチルスルホキシドと塩酸含有イソプロピ
ルアルコールとの混合液を用いることを特徴とするMT
T比色定量方法。1. An MT characterized by using a mixed solution of dimethylformamide and isopropyl alcohol containing hydrochloric acid or a mixed solution of dimethyl sulfoxide and isopropyl alcohol containing hydrochloric acid to dissolve MTT formazan crystals.
T colorimetric method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4934992A JPH05244993A (en) | 1992-03-06 | 1992-03-06 | Improved method for colorimetric determination of mtt |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4934992A JPH05244993A (en) | 1992-03-06 | 1992-03-06 | Improved method for colorimetric determination of mtt |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05244993A true JPH05244993A (en) | 1993-09-24 |
Family
ID=12828543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4934992A Pending JPH05244993A (en) | 1992-03-06 | 1992-03-06 | Improved method for colorimetric determination of mtt |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH05244993A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003525452A (en) * | 2000-03-01 | 2003-08-26 | 胡軍 | Method for determining the reactivity of blood lymphocytes to specific antigens |
-
1992
- 1992-03-06 JP JP4934992A patent/JPH05244993A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003525452A (en) * | 2000-03-01 | 2003-08-26 | 胡軍 | Method for determining the reactivity of blood lymphocytes to specific antigens |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kivirikko et al. | Modifications of a specific assay for hydroxyproline in urine | |
Attardi et al. | Malachite green, a valuable reagent to monitor the presence of free COOH on the solid-phase | |
JP2002303629A (en) | Immune chromatography device and method for determining substance to be tested using the same | |
CN102135498B (en) | Semi-quantitative colloidal metal detection technology taking multi-capture property as characteristic and preparation method and use thereof | |
Kudryavtsev et al. | Simultaneous bioluminescent immunoassay of serum total and IgG-bound prolactins | |
CN107966432A (en) | A kind of Soluble growth that measures stimulates the kit and its test method of 2 protein content of expressing gene | |
US3859047A (en) | Standard for serum cholesterol determination | |
JPH05244993A (en) | Improved method for colorimetric determination of mtt | |
Tankovskaia et al. | Spectral demonstration of structural transitions in albumins | |
CN104330576B (en) | A kind of cardic fatty acid binding protein detection reagent and preparation method thereof | |
DE102006021406A1 (en) | In vitro methods for the detection and early detection and the concomitant control of the therapy of drug- and addiction-induced liver damage | |
JPS6035119B2 (en) | Method for measuring factor X3 in plasma | |
CN108241064A (en) | A kind of kit and its test method for measuring thyroglobulin antibody content | |
DE69323244T2 (en) | Immunoassays using labeled thyronine analogs | |
US4822878A (en) | Cyclic anhydride derivatives of chromophors | |
Zandomeneghi et al. | Determination of holo-and apo-riboflavin binding protein in avian egg whites through circular dichroism and fluorescence spectroscopy | |
DE69316112T2 (en) | Immunoassays using horseradish peroxidase-labeled carbamazepine analogs | |
DE69931467T2 (en) | NEW COMPLEXES CONTAINING NETWORKED AVIDIN, METHOD OF MANUFACTURING AND ANALYSIS METHOD USING THIS | |
US4873318A (en) | Oxazine-ureas and thiazine urea chromophors | |
CN108196056A (en) | A kind of kit and its test method for measuring Carbohydrate Antigen 50 content | |
JPH0146118B2 (en) | ||
CN108226515A (en) | A kind of kit and its test method for measuring sex hormone binding globulin content | |
SU1120240A1 (en) | Method of identifying carbamazepine | |
Cole et al. | Skeletal dysplasias and disorders of cartilage matrix | |
CN116183923A (en) | Panel for detecting APC/tumor immune co-stimulatory molecules |